Lincoln Pharmaceuticals Ltd Nine Monthly Results

Gross Sales

455.05

438.06

397.85

369.54

344.61

Excise Duty

0

0

0

0

0

Net Sales

455.05

438.06

397.85

369.54

344.61

Other Operating Income

0

0

0

0

0

Other Income

29.36

27.4

18.57

8.11

3.13

Total Income

484.4

465.46

416.42

377.64

347.73

Total Expenditure

380.27

356.53

325.29

291.5

272.67

PBIDT

104.13

108.93

91.14

86.14

75.06

Interest

1.52

0.97

0.88

0.88

0.99

PBDT

102.62

107.96

90.26

85.26

74.08

Depreciation

9.67

7.94

6.75

6.09

5.67

Minority Interest Before NP

0

0

0

0

0

Tax

18.68

21.33

22.59

20.68

18.14

Deferred Tax

3.49

3.99

0.57

0.16

0.6

Reported Profit After Tax

70.77

74.71

60.34

58.33

49.67

Minority Interest After NP

0

0

0

0

0.02

Net Profit after Minority Interest

70.77

74.71

60.34

58.33

49.65

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

70.77

74.71

60.34

58.33

49.65

EPS (Unit Curr.)

35.33

37.3

30.12

29.12

24.79

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

20.03

20.03

20.03

20.03

20.03

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

22.88

24.86

22.9

23.31

21.78

PBDTM(%)

22.55

24.64

22.68

23.07

21.49

PATM(%)

15.55

17.05

15.16

15.78

14.41